Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.
NPJ Breast Cancer|June 8, 2022
Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significantLizelle Correia, Ramiro Magno, Joana M Xavier, et al.
JCO Precision Oncology|January 18, 2024
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) TrialIan E Krop, Lorenza Mittempergher, Joseph N Paulson, et al.
Cell|May 15, 2018
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic PotentialLiqin Wang, Rodrigo Leite de Oliveira, Sanne Huijberts, et al.
International Journal of Cancer|July 16, 2013
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transitionPaul Roepman, Andreas Schlicker, Josep Tabernero, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2024
An antibiotic that mediates immune destruction of senescent cancer cellsGabriele Casagrande Raffi, Jian Chen, Xuezhao Feng, et al.
Leukemia & Lymphoma|January 14, 2012
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibitionReinhard Dummer, Marc Beyer, Kenneth Hymes, et al.
Annals of Surgical Oncology|September 23, 2017
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free SurvivalCallisia N Clarke, Michael S Lee, Wei Wei, et al.
Plos One|September 6, 2022
Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activityZiva Pogacar, Jackie L Johnson, Lenno Krenning, et al.
Cell Reports|April 2, 2014
Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3Chong Sun, Sebastijan Hobor, Andrea Bertotti, et al.
Pageof 8